Basic Information
Basic information for LINC01684-210-23aa-2
Peptide Name LINC01684-210-23aa-2
Genome Position chr21:24438286-24438354[+]
Species Human
Peptide Sequence MPIFALAHFSNFIGIAPSKSPLF
Peptide Length 23
Unique No (LINC01684-202-23aa-1,LINC01684-203-23aa-1,LINC01684-204-23aa-2,LINC01684-206-23aa-2,LINC01684-207-23aa-2,LINC01684-208-23aa-2,LINC01684-211-23aa-1,LINC01684-212-23aa-2,LINC01684-213-23aa-2,LINC01684-214-23aa,LINC01684-215-23aa-2,LINC01684-216-23aa,LINC01684-217-23aa-2,LINC01684-218-23aa-2,LINC01684-222-23aa,LINC01684-223-23aa-2,LINC01684-224-23aa-1,LINC01684-225-23aa-1,LINC01684-226-23aa,LINC01684-227-23aa,LINC01684-228-23aa-1)
Grand Average of Hydropathicity 0.9304
Relative Molecular Mass 2902.29
Experimental Evidences no
lncRNA ID/Name ENSG00000237484;LINC01684
Transcript ID/Name ENST00000655241;LINC01684-210
Transcript Length 1232
Coding Ability 0.4692
DNA Sequence Corresponding to Peptide ATGCCTATTTTTGCACTCGCTCATTTTTCAAATTTCATAGGCATTGCTCCCTCCAAATCACCGCTCTTC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :